Certolizumab pegol Terminated Phase 3 Trials for Crohn's Disease (CD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00349752Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease
NCT00307931Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab